Holistic omics approach to allergic rhinitis

Completed

• Conditions: allergy; hay fever; 10046304

• Registration Number: NL-OMON43225
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

allergic rhinitis patients

Exclusion Criteria

participation in other studies
pregnancy
other chronic disease
medication intake for allergic rhinitis
under 18 year of age

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>differences of protein and RNA expression in nasal mucus and nasal epithelium<br /><br>respectively between allergic rhinitis patients and healthy controls</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>N/A</p><br>